Project Grant K99GM160698
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin–Madison a $580,507 Project Grant on May 6, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The five-year award, with a completion date of February 28, 2031, funds fundamental research investigating the mechanisms governing midbody remnants (MBRs)—a novel class of large extracellular vesicles released during cell division that...
- Summary of Federal Project Grant Award The Medical College of Wisconsin, Inc. received a $390,000 Project Grant awarded April 1, 2026, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859). The award funds a five-year research initiative examining metabolic regulation of immunity in Caenorhabditis elegans, with research performance conducted at the institution's Wauwatosa, Wisconsin facility through March 31, 2031....
- Federal Project Grant Award Summary The National Institute of General Medical Sciences awarded a $825,860 Project Grant to the University of Wisconsin–Madison (Award Date: August 1, 2025; Completion Date: May 31, 2030) under the Biomedical Research and Research Training program (CFDA 93.859). Under this award, Dr. Yesilkoy's research team will develop nanophotonic devices and quantum photonic technologies to enable sensing and non-destructive manipulation of biological systems at the molecular...
- Federal Grant Award Summary The University of Wisconsin–Madison received a $427,625 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective September 1, 2025, through August 31, 2027. The project develops and refines photoacoustic imaging (PAI) technology to quantitatively assess cutaneous wound healing by measuring biomarkers of...
- Federal Grant Award Summary The University of Wisconsin–Madison received a $413,001 Maximizing Investigators' Research Award (MIRA) Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through February 28, 2031. The award funds the development of computational systems and AI-powered software tools designed to address critical analytical challenges in single-cell and spatial...
- Federal Project Grant Award Summary The University of Michigan received a $409,941 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 5, 2026, with completion targeted for December 31, 2030. The research initiative focuses on developing translational treatments for chronic wound healing through cellular reprogramming strategies. The project addresses critical gaps in...
- Federal Project Grant Award Summary The University of Wisconsin-Madison received a $414,305 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion targeted for February 28, 2031. This five-year award supports the development and implementation of advanced statistical genetics tools designed to improve drug target discovery and treatment optimization. The...
- Project Grant Award Summary The University of Minnesota received a $398,144 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. The project focuses on engineering immunocompetent tissue models to advance understanding and treatment of inflammatory diseases. The research deliverables include the development of human pluripotent stem cell...
- Federal Grant Award Summary The University of Wisconsin-Milwaukee is receiving $563,880 in federal funding under a Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) through the Biomedical Research and Research Training program (CFDA 93.859). The award, effective September 1, 2025, through August 31, 2028, supports fundamental research into the regulators of the unfolded protein response (UPR) signaling pathway. The research will investigate how the three major...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $109,476 to the University of Wisconsin-Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) on November 30, 2025, with a completion date of May 31, 2027. This Project Grant supports fundamental research to understand the molecular mechanisms governing drug efflux in bacterial multidrug resistance transporters, specifically the NorA pump. The research...
The University of Wisconsin–Madison received a $116,005 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through April 30, 2028. This award supports fundamental research investigating the molecular mechanisms of reverse migration in neutrophil subpopulations during wound healing. The research employs zebrafish models and quantitative imaging techniques to identify key neutrophil populations involved in reverse migration, characterize their molecular profiles, and determine the necessity and sufficiency of specific subpopulations or molecular factors in promoting this process. The ultimate objective is to develop novel therapeutic strategies for controlled neutrophil clearance to resolve chronic inflammation and improve wound healing outcomes. The grant encompasses two complementary research phases: the K99 phase focuses on identifying and tracking neutrophil subpopulations during wound healing while training the investigator in advanced quantitative imaging methodologies, and the R00 phase investigates the role of opsin and phototransduction pathways in regulating neutrophil behavior. By integrating genetic and genomic approaches with cellular imaging, the research aims to establish the investigator as an independent researcher capable of designing innovative immunological interventions that leverage innate immune cell biology to enhance wound healing and tissue regeneration.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $116.0k | 4/30/26 |